Mechanisms of T-cell functional deficiency in the acquired immunodeficiency syndrome
- PMID: 2996404
- DOI: 10.7326/0003-4819-103-5-710
Mechanisms of T-cell functional deficiency in the acquired immunodeficiency syndrome
Abstract
Cell-mediated immune responses to cytomegalovirus infections were studied to define mechanisms for deficient effector T-cell responses in patients with the acquired immunodeficiency syndrome (AIDS). Progressive cytomegalovirus infection is common in such patients and is accompanied by a failure to develop HLA-restricted cytotoxic T-cell responses. The mechanism for the cytotoxic T-cell deficiency is presumably the basis for susceptibility to opportunistic infections. Precursors to these effector cells circulate in the peripheral blood of patients, but maturation of these cells into cytotoxic T cells is arrested during an interleukin-2-dependent phase. Production of interleukin-2 by lymphocytes from patients with AIDS is deficient because sera from these patients contain an inhibitor of interleukin-2 production. Excess suppressor cell activity does not appear to account for this deficient production. Studies of the source of the serum inhibitor should provide insights into the pathogenesis of AIDS and possible leads for effective treatment.
Similar articles
-
Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome.J Clin Invest. 1983 Jul;72(1):398-403. doi: 10.1172/jci110981. J Clin Invest. 1983. PMID: 6308051 Free PMC article.
-
Sera from patients with the acquired immunodeficiency syndrome inhibit production of interleukin-2 by normal lymphocytes.J Clin Invest. 1985 Jun;75(6):1957-64. doi: 10.1172/JCI111912. J Clin Invest. 1985. PMID: 2989337 Free PMC article.
-
Deficient, HLA-restricted, cytomegalovirus-specific cytotoxic T cells and natural killer cells in patients with the acquired immunodeficiency syndrome.J Infect Dis. 1985 Sep;152(3):627-30. doi: 10.1093/infdis/152.3.627. J Infect Dis. 1985. PMID: 2993445 No abstract available.
-
CD8+ cytotoxic T cell therapy of cytomegalovirus and HIV infection.Curr Opin Immunol. 1993 Aug;5(4):484-91. doi: 10.1016/0952-7915(93)90027-p. Curr Opin Immunol. 1993. PMID: 8216922 Review.
-
The importance of cytotoxic cellular immunity in the protection from cytomegalovirus infection.Birth Defects Orig Artic Ser. 1984;20(1):245-61. Birth Defects Orig Artic Ser. 1984. PMID: 6329365 Review. No abstract available.
Cited by
-
Immunologic abnormalities related to antigenaemia during HIV-1 infection.Clin Exp Immunol. 1988 Dec;74(3):317-20. Clin Exp Immunol. 1988. PMID: 2976619 Free PMC article.
-
Immune response to cytomegalovirus in patients with acquired-immunodeficiency syndrome related complex (ARC) and AIDS.Eur J Epidemiol. 1987 Dec;3(4):439-41. doi: 10.1007/BF00145659. Eur J Epidemiol. 1987. PMID: 2826223
-
Impairment in T-lymphocyte responses during early infection with the human immunodeficiency virus.J Clin Immunol. 1989 Mar;9(2):159-68. doi: 10.1007/BF00916944. J Clin Immunol. 1989. PMID: 2785531
-
Lymphocyte subpopulation profiles and mitogen kinetics in immunological deficiency testing.J Clin Immunol. 1987 Jul;7(4):312-8. doi: 10.1007/BF00915553. J Clin Immunol. 1987. PMID: 2956275
-
Isolation of Rare Antigen-Specific Memory B Cells via Antigen Tetramers.Methods Mol Biol. 2024;2826:95-115. doi: 10.1007/978-1-0716-3950-4_8. Methods Mol Biol. 2024. PMID: 39017888
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials